Qube Research & Technologies LTD Spring Works Therapeutics, Inc. Transaction History
Qube Research & Technologies LTD
- $93.8 Billion
 - Q2 2025
 
A detailed history of Qube Research & Technologies LTD transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 51,529 shares of SWTX stock, worth $2.42 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,529
              Previous 444,373
              
        
           88.4%
        
      
          
        Holding current value
$2.42 Million
            Previous $19.6 Million
            
        
           87.65%
        
      
          
        % of portfolio
0.0%
            Previous 0.02%
          
        Shares
	  14 transactions
	
  Others Institutions Holding SWTX
# of Institutions
236Shares Held
70.3MCall Options Held
11.4MPut Options Held
1.27M- 
    
      Vanguard Group Inc Valley Forge, PA7.13MShares$335 Million0.01% of portfolio
 - 
    
      Black Rock Inc. New York, NY5.62MShares$264 Million0.0% of portfolio
 - 
    
      Glazer Capital, LLC New York, NY4.11MShares$193 Million6.9% of portfolio
 - 
    
      Fil LTD Hamilton, D03.01MShares$142 Million0.13% of portfolio
 - 
    
      State Street Corp Boston, MA2.99MShares$141 Million0.01% of portfolio
 
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
 - Exchange NASDAQ
 - Sector Healthcare
 - Industry Biotechnology
 - Shares Outstandng 62,401,100
 - Market Cap $2.93B
 - Description
 - SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...